Drug pathways: moving beyond single gene pharmacogenetics

This publication has 22 references indexed in Scilit:

• Cancer pharmacogenetics: polymorphisms, pathways and beyond
  Nature Reviews Cancer, 2003
• Drug methylation in cancer therapy: lessons from the TPMT polymorphism
  Oncogene, 2003
• Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1
  New England Journal of Medicine, 2003
• Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
  New England Journal of Medicine, 2003
• Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
  The Lancet, 2002
• Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
  Clinical Pharmacokinetics, 2002
• The thiopurine S-methyltransferase gene locus – implications for clinical pharmacogenomics
  Pharmacogenomics, 2002
• Pharmacogenomics: Unlocking the Human Genome for Better Drug Therapy
  Annual Review of Pharmacology and Toxicology, 2001
• Complex promoter and coding region β ₂ -adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness
  Proceedings of the National Academy of Sciences, 2000
• Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype
  Pharmacogenetics, 1995